← All trials
NCT02145338
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2013
- Primary completion
- Feb 22, 2017
- Completion date
- Feb 22, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 404
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Newcastle UniversityLead sponsor
- Newcastle UniversityOverall official - principal investigator
- Newcastle UniversityCollaborator
- University of AberdeenCollaborator
- University of BristolCollaborator
- Moorgreen Hospital, SouthamptonCollaborator
- NHS Health Technology Assessment ProgrammeCollaborator
- Glasgow Caledonian UniversityCollaborator
- University of CambridgeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.